Preparation, COX-2 Inhibition and Anticancer Activity of Sclerotiorin Derivatives
The latest research has indicated that anti-tumor agents with COX-2 inhibitory activity may benefit their anti-tumor efficiency. A series of sclerotiorin derivatives have been synthesized and screened for their cytotoxic activity against human lung cancer cells A549, breast cancer cells MDA-MB-435 u...
Main Authors: | Tao Chen, Yun Huang, Junxian Hong, Xikang Wei, Fang Zeng, Jialin Li, Geting Ye, Jie Yuan, Yuhua Long |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-12-01
|
Series: | Marine Drugs |
Subjects: | |
Online Access: | https://www.mdpi.com/1660-3397/19/1/12 |
Similar Items
-
Crystallography, Molecular Modeling, and COX-2 Inhibition Studies on Indolizine Derivatives
by: Katharigatta N. Venugopala, et al.
Published: (2021-06-01) -
Cyclooxygenase-2 (COX-2) as a Target of Anticancer Agents: A Review of Novel Synthesized Scaffolds Having Anticancer and COX-2 Inhibitory Potentialities
by: Noor ul Amin Mohsin, et al.
Published: (2022-11-01) -
Design, synthesis, molecular docking studies and biological evaluation of thiazole carboxamide derivatives as COX inhibitors
by: Mohammed Hawash, et al.
Published: (2023-03-01) -
Toward Multitasking Pharmacological COX-Targeting Agents: Non-Steroidal Anti-Inflammatory Prodrugs with Antiproliferative Effects
by: Fedora Grande, et al.
Published: (2021-06-01) -
New pyrazolyl-thiazolidinone/thiazole derivatives as celecoxib/dasatinib analogues with selective COX-2, HER-2 and EGFR inhibitory effects: design, synthesis, anti-inflammatory/anti-proliferative activities, apoptosis, molecular modelling and ADME studies
by: Wael A. A. Fadaly, et al.
Published: (2023-12-01)